Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma.
about
CIK Cells and HDAC Inhibitors in Multiple Myeloma.Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.All-trans retinoic acid enhances cytotoxicity of CIK cells against human lung adenocarcinoma by upregulating MICA and IL-2 secretion.Mechanisms of Intrinsic Tumor Resistance to Immunotherapy.
P2860
Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Increase of CIK cell efficacy ...... shedding in multiple myeloma.
@en
Increase of CIK cell efficacy ...... shedding in multiple myeloma.
@nl
type
label
Increase of CIK cell efficacy ...... shedding in multiple myeloma.
@en
Increase of CIK cell efficacy ...... shedding in multiple myeloma.
@nl
prefLabel
Increase of CIK cell efficacy ...... shedding in multiple myeloma.
@en
Increase of CIK cell efficacy ...... shedding in multiple myeloma.
@nl
P2093
P2860
P356
P1476
Increase of CIK cell efficacy ...... shedding in multiple myeloma.
@en
P2093
Chidimma A Nwangwu
Hans Weiher
Ingo G H Schmidt-Wolf
P2860
P304
P356
10.1002/HON.2326
P577
2016-07-19T00:00:00Z